速递|14.2亿元甩卖口服胰岛素梦:华润踩雷十年止损

GLP1减重宝典
Feb 14

整理 | GLP1减重宝典内容团队2月9日,华润医药公告拟在上海联合产权交易所以公开挂牌方式,出售所持合肥天麦生物约17.87%股权,挂牌底价约14.2亿元。对外界而言,这更像一次普通的资产处置;但放在时间轴上看,它是华润医药一段跨界豪赌的“清算时刻”。十年前,华润在寻求从传统分销与仿制药思路向生物制药转身时,选择了胰岛素这条确定性更强、利润更厚的赛道,并把最激进的筹码压在口服胰岛素上。如今,口服...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10